Study of High Efficient Killing Cell Therapy for Advanced NSCLC

PHASE1RecruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

September 14, 2017

Primary Completion Date

May 1, 2025

Study Completion Date

May 1, 2025

Conditions

Non Small Cell Lung Cancer

Interventions

BIOLOGICAL

HEKT cell

3 cycles of HEKT cell treatment

Trial Locations (1)

RECRUITING

Ruijin Hospital, Shanghai

All Listed Sponsors

collaborator

Shanghai Houchao Biotechnology Co., Ltd

UNKNOWN

lead

Ruijin Hospital

OTHER